AAAAAA

   
Results: 1-5 |
Results: 5

Authors: GORDON GS BROCKSTEIN BE HARAF DJ KIES MS STENSON K SULZEN L WEICHSELBAUM RR VOKES EE
Citation: Gs. Gordon et al., A PHASE-II STUDY OF INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CANCER, Journal of investigative medicine, 46(7), 1998, pp. 255-255

Authors: VOKES EE HUMERICKHOUSE R DOLAN E BROCKSTEIN B HARAF D STENSON K KIES M SULZEN L HOUSE L RATAIN MJ
Citation: Ee. Vokes et al., PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC), Annals of oncology, 9, 1998, pp. 597-597

Authors: BROCKSTEIN B HARAF DJ STENSON K FASANMADE A STUPP R GLISSON B LIPPMAN SM RATAIN MJ SULZEN L KLEPSCH A WEICHSELBAUM RR VOKES EE
Citation: B. Brockstein et al., PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK, Journal of clinical oncology, 16(2), 1998, pp. 735-744

Authors: HARAF DJ STENSON K WITT ME LIST M SULZEN L WEICHSELBAUM RR VOKES EE
Citation: Dj. Haraf et al., CONCOMITANT RADIOTHERAPY, PACLITAXEL, 5-FLUOROURACIL, AND HYDROXYUREAIN PATIENTS WITH ADVANCED OR RECURRENT HEAD AND NECK-CANCER, Seminars in radiation oncology, 7(2), 1997, pp. 34-38

Authors: MCINTOSH RA SULZEN L REEDER K KIDD DH
Citation: Ra. Mcintosh et al., MAKING SCIENCE ACCESSIBLE TO DEAF STUDENTS - THE NEED FOR SCIENCE LITERACY AND CONCEPTUAL TEACHING, American annals of the deaf, 139(5), 1994, pp. 480-484
Risultati: 1-5 |